1. Home
  2. SNCR vs DXR Comparison

SNCR vs DXR Comparison

Compare SNCR & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Synchronoss Technologies Inc.

SNCR

Synchronoss Technologies Inc.

HOLD

Current Price

$8.54

Market Cap

59.5M

Sector

Technology

ML Signal

HOLD

Logo Daxor Corporation

DXR

Daxor Corporation

N/A

Current Price

$12.25

Market Cap

61.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SNCR
DXR
Founded
2000
1970
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
59.5M
61.5M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
SNCR
DXR
Price
$8.54
$12.25
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$25.00
AVG Volume (30 Days)
278.6K
4.3K
Earning Date
11-04-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.46
EPS
N/A
0.36
Revenue
$170,909,000.00
$66,306.00
Revenue This Year
$0.30
N/A
Revenue Next Year
$5.43
N/A
P/E Ratio
N/A
$33.97
Revenue Growth
0.07
N/A
52 Week Low
$3.98
$6.55
52 Week High
$12.85
$14.15

Technical Indicators

Market Signals
Indicator
SNCR
DXR
Relative Strength Index (RSI) 78.10 40.20
Support Level $8.45 $12.11
Resistance Level $8.60 $13.02
Average True Range (ATR) 0.25 0.47
MACD 0.37 -0.09
Stochastic Oscillator 92.33 6.75

Price Performance

Historical Comparison
SNCR
DXR

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

About DXR Daxor Corporation

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.

Share on Social Networks: